Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

United Therapeutics buy UBS Group AG

United Therapeutics
Start price
€292.80
08.07.24 / 50%
Target price
€341.51
08.07.25
Performance (%)
-14.82%
End price
€249.40
09.07.25
Summary
This prediction ended on 09.07.25 with a price of €249.40. The prediction for United Therapeutics disappointed with a performance of -14.82%. UBS_Group_AG has a follow-up prediction for United Therapeutics where he still thinks United Therapeutics is a Buy. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
United Therapeutics 2.389% 2.389% 14.898%
iShares Core DAX® 0,19 % -1,22 % 8,84 %
iShares Nasdaq 100 -1,35 % -5,31 % -1,14 %
iShares Nikkei 225® -0,43 % 7,32 % 27,58 %
iShares S&P 500 -1,01 % -3,40 % -0,22 %

Comments by UBS_Group_AG for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) -14.82%
Target price 341.510
Change
Ends at 08.07.25

United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $300.00 to $370.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat

UBS Group AG 
0
Report Share
08.07.24
In the thread Trading United Therapeutics
Prediction Buy
Perf. (%) -14.82%
Target price 341.510
Change
Ends at 08.07.25

Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

UBS Group AG 
0
Report Share
09.07.25

Current prediction by UBS_Group_AG for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€244.10
30.06.25
€328.48
30.06.26
66.82%
17.02.26

UBS Group AG 
30.06.25 50%

Stopped prediction by UBS_Group_AG for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€407.20
17.02.26
-
17.02.27
0.00%
17.02.26

UBS Group AG 
17.02.26 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€426.10
06.01.26
€550.12
06.01.27
-4.53%
17.02.26

UBS Group AG 
06.01.26 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€393.20
06.11.25
€521.34
06.11.26
3.56%
17.02.26

UBS Group AG 
06.11.25 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€360.40
29.09.25
€494.80
29.09.26
12.99%
17.02.26

UBS Group AG 
29.09.25 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€337.60
04.09.25
€480.20
04.09.26
20.62%
17.02.26

UBS Group AG 
04.09.25 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€258.80
13.08.25
€355.41
13.08.26
57.34%
17.02.26

UBS Group AG 
13.08.25 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€355.30
08.01.25
€460.94
08.01.26
17.73%
09.01.26

UBS Group AG 
08.01.25 50%